Sun Pharma Advanced Research Company fell 2.22% to Rs 380.95 at 15:02 IST on BSE after the company reported a net loss of Rs 17.74 crore in Q2 September 2015 compared with net loss of Rs 1.47 crore in Q2 September 2014.
The result was announced during trading hours today, 4 November 2015.
Meanwhile, the BSE Sensex was down 2 points, or 0.01%, to 26,588.59.
On BSE, so far 3.12 lakh shares were traded in the counter, compared with an average volume of 1.88 lakh shares in the past one quarter.
The stock hit a high of Rs 399 and a low of Rs 377 so far during the day. The stock hit a record high of Rs 598 on 10 March 2015. The stock hit a 52-week low of Rs 171 on 17 December 2014.
Also Read
The stock had outperformed the market over the past one month till 3 November 2015, rising 1.42% compared with 1.41% rise in the Sensex. The scrip had also outperformed the market in past one quarter, falling 2.66% as against Sensex's 5.66% decline.
The mid-cap company has an equity capital of Rs 23.67 crore. Face value per share is Re 1.
Sun Pharma Advanced Research Company (SPARC)'s total income fell 7% to Rs 43.33 crore in Q2 September 2015 over Q2 September 2014.
SPARC is an international pharmaceutical company engaged in research and development of drugs and delivery systems.
Powered by Capital Market - Live News
